Nivolumab for the treatment of urothelial cancers-Reference-Cited by-同舟云学术

Nivolumab for the treatment of urothelial cancers

Published:2018-01-31 Issue:3 Volume:18 Page:215-221
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Teo Min Yuen¹,Rosenberg Jonathan E.¹

Affiliation:

1. Department of Medicine, Division of Solid Tumor Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2018.1432357

Reference54 articles.

1. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

2. Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

3. International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Urinary Microbiome in Health and Disease: Relevance for Bladder Cancer;International Journal of Molecular Sciences;2024-01-31

2. Hyperbaric oxygen enhanced the chemotherapy of mitochondrial targeting molecule IR-780 in bladder cancer;Journal of Cancer Research and Clinical Oncology;2022-11-27

3. A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma;International Journal of Molecular Sciences;2022-10-12

4. Bladder cancer, inflammageing and microbiomes;Nature Reviews Urology;2022-07-07

5. Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma;Frontiers in Cell and Developmental Biology;2022-02-23